Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients.

Autor: NIAN-XIN JIANG1, JUN-WEI GE1, YU-QIONG XIAN1, SHAO-YING HUANG1, YAN-SONG LI1 liyssh@163.com
Zdroj: Biomedical Reports. Apr2016, Vol. 4 Issue 4, p453-458. 6p.
Databáze: Academic Search Ultimate